Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the recipient of a large decrease in short interest in August. As of August 31st, there was short interest totaling 417 shares, a decrease of 67.8% from the August 15th total of 1,295 shares. Based on an average trading volume of 2,661 shares, the short-interest ratio is currently 0.2 days. Currently, 0.0% of the company’s shares are short sold.
Gyrodyne Stock Performance
Gyrodyne stock traded up $0.04 during midday trading on Monday, reaching $5.03. 7,972 shares of the stock traded hands, compared to its average volume of 2,636. The company has a 50-day simple moving average of $5.50 and a two-hundred day simple moving average of $6.76. Gyrodyne has a 12-month low of $4.95 and a 12-month high of $10.90.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
See Also
- Five stocks we like better than Gyrodyne
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
